KoACT, a patented chelated compound of calcium and hydrolyzed collagen peptides from AIDP, has received GRAS (Generally Recognized as Safe) status. KoACT has been shown to support both bone strength and bone mineral density in animal studies and to increase biomarkers of bone growth in human studies.
AIBMR Life Sciences, Inc., evaluated the safety assessment of KoACT and concluded its intended use as a food ingredient is produced in accordance with Good Manufacturing Practices. The AIBMR panel concluded that the addition levels per food serving are GRAS based upon scientific procedures and corroborated by an extensive history of safe use.
“The bone and joint health market are expected to reach over $4 billion by 2013, and we feel KoACT is positioned to take a large portion of that health category,” said Kathy Lund, director of business development and marketing.
Suggested delivery forms for KoACT are tablets, capsules, soft-gels and functional food applications.